Overexpression of HOXB4 enhances the hematopoietic potential of embryonic stem cells differentiated in vitro.

Abstract:

:Little is known about the molecular mechanisms controlling primitive hematopoietic stem cells, especially during embryogenesis. Homeobox genes encode a family of transcription factors that have gained increasing attention as master regulators of developmental processes and recently have been implicated in the differentiation and proliferation of hematopoietic cells. Several Hox homeobox genes are now known to be differentially expressed in various subpopulations of human hematopoietic cells and one such gene, HOXB4, has recently been shown to positively determine the proliferative potential of primitive murine bone marrow cells, including cells with long-term repopulating ability. To determine if this gene might influence hematopoiesis at the earliest stages of development, embryonic stem (ES) cells were genetically modified by retroviral gene transfer to overexpress HOXB4 and the effect on their in vitro differentiation was examined. HOXB4 overexpression significantly increased the number of progenitors of mixed erythroid/myeloid colonies and definitive, but not primitive, erythroid colonies derived from embryoid bodies (EBs) at various stages after induction of differentiation. There appeared to be no significant effect on the generation of granulocytic or monocytic progenitors, nor on the efficiency of EB formation or growth rate. Analysis of mRNA from EBs derived from HOXB4-transduced ES cells on different days of primary differentiation showed a significant increase in adult beta-globin expression, with no detectable effect on GATA-1 or embryonic globin (beta H-1). Thus, HOXB4 enhances the erythropoietic, and possibly more primitive, hematopoietic differentiative potential of ES cells. These results provide new evidence implicating Hox genes in the control of very early stages in the development of the hematopoietic system and highlight the utility of the ES model for gaining insights into the molecular genetic regulation of differentiation and proliferation events.

journal_name

Blood

journal_title

Blood

authors

Helgason CD,Sauvageau G,Lawrence HJ,Largman C,Humphries RK

subject

Has Abstract

pub_date

1996-04-01 00:00:00

pages

2740-9

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

87

pub_type

杂志文章

相关文献

BLOOD文献大全
  • AU-rich RNA binding proteins in hematopoiesis and leukemogenesis.

    abstract::Posttranscriptional mechanisms are now widely acknowledged to play a central role in orchestrating gene-regulatory networks in hematopoietic cell growth, differentiation, and tumorigenesis. Although much attention has focused on microRNAs as regulators of mRNA stability/translation, recent data have highlighted the ro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-347237

    authors: Baou M,Norton JD,Murphy JJ

    更新日期:2011-11-24 00:00:00

  • Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.

    abstract::The granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is a potential target for toxin-directed therapy, because it is overexpressed on many leukemias and solid tumors and apparently not on stem cells. To investigate the potential therapeutic use of GM-CSF toxins, we fused human GM-CSF to truncated fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kreitman RJ,Pastan I

    更新日期:1997-07-01 00:00:00

  • Killer cell activity of human monoblastic leukemia cells as detected with a monocyte-specific target cell.

    abstract::Peripheral blood leukemia cells from patients with acute monoblastic leukemia (AMoL) were tested for killer cell activity against target cells that detected natural killer cell-mediated or monocyte-mediated spontaneous cytotoxicity. The fibrosarcoma cell line Wehi 164, pretreated with actinomycin D to induce susceptib...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ziegler-Heitbrock HW,Munker R,Thiel E,Krebs I,Riethmüller G

    更新日期:1985-01-01 00:00:00

  • Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor.

    abstract::Although preclinical work with rapalogs suggests potential in treatment of multiple myeloma (MM), they have been less successful clinically. These drugs allostearically inhibit the mammalian target of rapamycin kinase primarily curtailing activity of the target of rapamycin complex (TORC)1. To assess if the mammalian ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285726

    authors: Hoang B,Frost P,Shi Y,Belanger E,Benavides A,Pezeshkpour G,Cappia S,Guglielmelli T,Gera J,Lichtenstein A

    更新日期:2010-11-25 00:00:00

  • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies.

    abstract::We aimed to determine the prognostic impact of monosomal karyotype (MK) in acute myeloid leukemia (AML) in the context of the current World Health Organization (WHO) classification and to evaluate the outcome of MK(+) patients after allogeneic HSCT. Of 1058 patients with abnormal cytogenetics, 319 (30%) were MK MK(+)....

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2011-07-367508

    authors: Kayser S,Zucknick M,Döhner K,Krauter J,Köhne CH,Horst HA,Held G,von Lilienfeld-Toal M,Wilhelm S,Rummel M,Germing U,Götze K,Nachbaur D,Schlegelberger B,Göhring G,Späth D,Morlok C,Teleanu V,Ganser A,Döhner H,Schlenk

    更新日期:2012-01-12 00:00:00

  • Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.

    abstract::Chemotherapy-related myeloid neoplasia (t-MN) is a significant late toxicity concern after cancer therapy. In the randomized intergroup phase 3 E2997 trial, initial therapy of chronic lymphocytic leukemia with fludarabine plus cyclophosphamide (FC) compared with fludarabine alone yielded higher complete and overall re...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-03-342485

    authors: Smith MR,Neuberg D,Flinn IW,Grever MR,Lazarus HM,Rowe JM,Dewald G,Bennett JM,Paietta EM,Byrd JC,Hussein MA,Appelbaum FR,Larson RA,Litzow MR,Tallman MS

    更新日期:2011-09-29 00:00:00

  • Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC).

    abstract::Hand mirror cells are a morphological configuration that are seen in immunologically stimulated lymphocytes and can be induced by antigen--antibody complexes. Therefore, the bone marrow and peripheral blood plasma of two patients with acute lymphoblastic leukemia--hand mirror variant were evaluated for the presence of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stass SA,Phillips TM,Weislow OS,Perlin E,Schumacher HR

    更新日期:1980-10-01 00:00:00

  • Extracellular histones induce erythrocyte fragility and anemia.

    abstract::Extracellular histones have been shown to play an important pathogenic role in many diseases, primarily through their cytotoxicity toward nucleated cells and their ability to promote platelet activation with resultant thrombosis and thrombocytopenia. In contrast, little is known about the effect of extracellular histo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-790519

    authors: Kordbacheh F,O'Meara CH,Coupland LA,Lelliott PM,Parish CR

    更新日期:2017-12-28 00:00:00

  • The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question.

    abstract::Choosing Wisely® is a medical stewardship and quality improvement initiative led by the American Board of Internal Medicine Foundation in collaboration with leading medical societies in the United States. The ASH is an active participant in the Choosing Wisely® project. Using an iterative process and an evidence-based...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-07-518423

    authors: Hicks LK,Bering H,Carson KR,Kleinerman J,Kukreti V,Ma A,Mueller BU,O'Brien SH,Pasquini M,Sarode R,Solberg L Jr,Haynes AE,Crowther MA

    更新日期:2013-12-05 00:00:00

  • An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia.

    abstract::Acute myeloid leukemia (AML) is a major unmet medical need. Most patients have poor long-term survival, and treatment has not significantly changed in 40 years. Recently, bispecific antibodies that redirect the cytotoxic activity of effector T cells by binding to CD3, the signaling component of the T-cell receptor, an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-735365

    authors: Leong SR,Sukumaran S,Hristopoulos M,Totpal K,Stainton S,Lu E,Wong A,Tam L,Newman R,Vuillemenot BR,Ellerman D,Gu C,Mathieu M,Dennis MS,Nguyen A,Zheng B,Zhang C,Lee G,Chu YW,Prell RA,Lin K,Laing ST,Polson AG

    更新日期:2017-02-02 00:00:00

  • Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

    abstract::Severe aplastic anemia (SAA) can be successfully treated with allogeneic bone marrow transplantation (BMT) or immunosuppressive therapy. However, the majority of patients with SAA are not eligible for BMT because they lack an HLA-identical sibling. Conventional immunosuppressive therapy also has major limitations; man...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Brodsky RA,Sensenbrenner LL,Jones RJ

    更新日期:1996-01-15 00:00:00

  • Infants with acute lymphoblastic leukemia and a germline MLL gene are highly curable with use of chemotherapy alone: results from the Japan Infant Leukemia Study Group.

    abstract::Although infants with acute lymphoblastic leukemia (ALL) and a germline MLL gene have a better prognosis than comparable infants with a rearranged MLL gene, their optimal therapy is controversial. In 2 consecutive studies, conducted between 1996 and 2002, we treated 22 cases of infant ALL with germline MLL using chemo...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2005-11-4728

    authors: Nagayama J,Tomizawa D,Koh K,Nagatoshi Y,Hotta N,Kishimoto T,Takahashi Y,Kuno T,Sugita K,Sato T,Kato K,Ogawa A,Nakahata T,Mizutani S,Horibe K,Ishii E,Japan Infant Leukemia Study Group.

    更新日期:2006-06-15 00:00:00

  • Wild-type FOXP3 is selectively active in CD4+CD25(hi) regulatory T cells of healthy female carriers of different FOXP3 mutations.

    abstract::Forkhead box P3 (FOXP3) is constitutively expressed by CD4(+)CD25(hi) regulatory T cells (nTregs). Mutations of FOXP3 cause a severe autoimmune syndrome known as immune dysregulation polyendocrinopathy enteropathy X-linked, in which nTregs are absent or dysfunctional. Whether FOXP3 is essential for both differentiatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-04-214593

    authors: Di Nunzio S,Cecconi M,Passerini L,McMurchy AN,Baron U,Turbachova I,Vignola S,Valencic E,Tommasini A,Junker A,Cazzola G,Olek S,Levings MK,Perroni L,Roncarolo MG,Bacchetta R

    更新日期:2009-11-05 00:00:00

  • The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria.

    abstract::Pattern recognition receptors (PRRs) play an essential role in a macrophage's response to mycobacterial infections. However, how these receptors work in concert to promote this macrophage response remains unclear. In this study, we used bone marrow-derived macrophages isolated from mannose receptor (MR), complement re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-024406

    authors: Yadav M,Schorey JS

    更新日期:2006-11-01 00:00:00

  • Pre-pre-B acute lymphoblastic leukemia: high frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission.

    abstract::We used the polymerase chain reaction (PCR) to detect ALL1-AF4 rearrangements, the molecular hallmark of t(4;11) in a series of 46 pre-pre-B (CD19+, CD24+, CD10/CD20/cylgM/sIgM-) acute lymphoblastic leukemias (ALL). Eighteen patients (39%) exhibited fusion transcripts including 4 of 12 children and 14 of 34 adults. Th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Janssen JW,Ludwig WD,Borkhardt A,Spadinger U,Rieder H,Fonatsch C,Hossfeld DK,Harbott J,Schulz AS,Repp R

    更新日期:1994-12-01 00:00:00

  • IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice.

    abstract::Posttransplantation lymphoproliferative disorder (PTLD) is a devastating post-transplantation complication often associated with Epstein-Barr virus (EBV). Although the type and length of immunosuppression are risk factors, a patient's inherent immune capacity also likely contributes to this disorder. This report uses ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2476

    authors: Dierksheide JE,Baiocchi RA,Ferketich AK,Roychowdhury S,Pelletier RP,Eisenbeis CF,Caligiuri MA,VanBuskirk AM

    更新日期:2005-02-15 00:00:00

  • Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish.

    abstract::Isocitrate dehydrogenase 1 mutation (IDH1-R132H) was recently identified in acute myeloid leukemia with normal cytogenetics. The mutant enzyme is thought to convert α-ketoglutarate to the pathogenic 2-hydroxyglutarate (2-HG) that affects DNA methylation via inhibition of ten-eleven translocation 2. However, the role o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-601187

    authors: Shi X,He BL,Ma AC,Guo Y,Chi Y,Man CH,Zhang W,Zhang Y,Wen Z,Cheng T,Leung AY

    更新日期:2015-05-07 00:00:00

  • Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model.

    abstract::Transfusion-related acute lung injury (TRALI) is a hazardous complication of transfusion and has become the leading cause of transfusion-related death in the United States and United Kingdom. Although leukoagglutinating antibodies have been frequently shown to be associated with the syndrome, the mechanism by which th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1744

    authors: Sachs UJ,Hattar K,Weissmann N,Bohle RM,Weiss T,Sibelius U,Bux J

    更新日期:2006-02-01 00:00:00

  • A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users.

    abstract::Infection with human T-cell leukemia virus type II (HTLV-II) has been associated with rare chronic T-cell malignancies and has recently been demonstrated in a significant proportion of American intravenous drug abusers (IVDA). Identification of an HTLV-II-infected cohort of IVDA has allowed analysis of the HTLV-II car...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosenblatt JD,Plaeger-Marshall S,Giorgi JV,Swanson P,Chen IS,Chin E,Wang HJ,Canavaggio M,Hausner MA,Black AC

    更新日期:1990-07-15 00:00:00

  • Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

    abstract::The paradoxical correlation between thrombosis and the lupus anticoagulant (LAC) effect is an enigmatic feature of the antiphospholipid (aPL) syndrome. The Dutch authors previously reported that thrombosis-related anti-beta2-glycoprotein I (beta2GPI) antibodies recognize domain I and cause LAC. The American authors re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-030148

    authors: de Laat B,Wu XX,van Lummel M,Derksen RH,de Groot PG,Rand JH

    更新日期:2007-02-15 00:00:00

  • BCR-ABL/p62/SQSTM1: a cannibal embrace.

    abstract::In this issue of Blood, Goussetis et al identify autophagy as a new pathway for the degradation of the oncoprotein BCR-ABL. They show that the therapeutic drug arsenic trioxide (AS(2)O(3)) targets BCR-ABL for autophagic degradation via a p62/SQSTM1-dependent mechanism that is critical for the antileukemic effect of th...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-08-451492

    authors: Auberger P

    更新日期:2012-10-25 00:00:00

  • Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.

    abstract::Virally infected cells degrade intracellular viral proteins proteolytically and present the resulting peptides in association with major histocompatibility complex (MHC) class I molecules to CD8+ cytotoxic T lymphocytes (CTLs). These cells are normally prone to CTL-mediated elimination. However, several viruses have e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zeidler R,Eissner G,Meissner P,Uebel S,Tampé R,Lazis S,Hammerschmidt W

    更新日期:1997-09-15 00:00:00

  • Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab.

    abstract::Epratuzumab, a humanized anti-CD22 antibody, is currently in clinical trials of B-cell lymphomas and autoimmune diseases, demonstrating therapeutic activity in non-Hodgkin lymphoma (NHL) and systemic lupus erythematosus (SLE). Thus, epratuzumab offers a promising option for CD22-targeted immunotherapy, yet its mechani...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-473744

    authors: Rossi EA,Goldenberg DM,Michel R,Rossi DL,Wallace DJ,Chang CH

    更新日期:2013-10-24 00:00:00

  • Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia.

    abstract::Chimeric antigen receptor (CAR) T cells have radically improved the treatment of B cell-derived malignancies by targeting CD19. The success has not yet expanded to treat acute myeloid leukemia (AML). We developed a Sequentially Tumor-Selected Antibody and Antigen Retrieval (STAR) system to rapidly isolate multiple nan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019002779

    authors: He X,Feng Z,Ma J,Ling S,Cao Y,Gurung B,Wu Y,Katona BW,O'Dwyer KP,Siegel DL,June CH,Hua X

    更新日期:2020-03-05 00:00:00

  • Cytosolic free calcium changes induced by chemotactic peptide in neutrophils from patients with chronic granulomatous disease.

    abstract::Cytoplasmic free calcium concentration (Ca2+)i was measured in neutrophils from patients with the classical X-linked form of chronic granulomatous disease (CGD) by trapping the fluorescent calcium indicator Quin 2 in intact cells. CGD neutrophils do not produce superoxide and are only slightly depolarized upon stimula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lew PD,Wollheim C,Seger RA,Pozzan T

    更新日期:1984-01-01 00:00:00

  • Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid.

    abstract::6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) is a novel compound that represents the prototype of a new class of synthetic retinoids with apoptogenic properties in acute promyelocytic leukemia (APL) and other types of leukemia. In this article, using SCID mice xenografted with APL-derived NB4 ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ponzanelli I,Giannì M,Giavazzi R,Garofalo A,Nicoletti I,Reichert U,Erba E,Rambaldi A,Terao M,Garattini E

    更新日期:2000-04-15 00:00:00

  • Glanzmann thrombasthenia caused by an 11.2-kb deletion in the glycoprotein IIIa (beta3) is a second mutation in Iraqi Jews that stemmed from a distinct founder.

    abstract::Glanzmann thrombasthenia (GT) is a rare bleeding disorder resulting from mutations in either glycoprotein (GP) IIb or GPIIIa genes. The disease is relatively frequent in highly inbred populations such as Iraqi Jews. The molecular basis of GT in 6 unrelated Iraqi-Jewish patients was previously identified as an 11-bp de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rosenberg N,Yatuv R,Orion Y,Zivelin A,Dardik R,Peretz H,Seligsohn U

    更新日期:1997-05-15 00:00:00

  • Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model.

    abstract::In an effort to develop a clinically useful approach to overcoming P-glycoprotein-mediated multidrug resistance (MDR1), we evaluated combined chemosensitization with verapamil and quinine in a multidrug-resistant (MDR) human myeloma cell line model. In clonogenic assay, verapamil was used at concentrations from 0.1 to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lehnert M,Dalton WS,Roe D,Emerson S,Salmon SE

    更新日期:1991-01-15 00:00:00

  • Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome.

    abstract::The putative chemokine receptor BLR1 has been identified as the first G-protein-coupled receptor involved in B-cell migration and in microenvironmental homing to B-cell follicles and to germinal centers. In healthy individuals, expression of BLR1 is restricted to all mature recirculating B cells and to a subpopulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Förster R,Schweigard G,Johann S,Emrich T,Kremmer E,Nerl C,Lipp M

    更新日期:1997-07-15 00:00:00

  • Ligation of CD31 (PECAM-1) on endothelial cells increases adhesive function of alphavbeta3 integrin and enhances beta1 integrin-mediated adhesion of eosinophils to endothelial cells.

    abstract::We determined the role of the heterophilic interaction of alphavbeta3 integrin on endothelial cells with CD31 on leukocytes in mediating leukocyte-endothelial cell interactions. Preincubation of interleukin-4 (IL-4)-stimulated human umbilical vein endothelial cells (HUVECs) with anti-CD31 monoclonal antibodies (MoAbs)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chiba R,Nakagawa N,Kurasawa K,Tanaka Y,Saito Y,Iwamoto I

    更新日期:1999-08-15 00:00:00